EXHIBIT 23.1
Published on March 7, 2019
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-218285) and Form S-8 (File No. 333-189240,
333-129294 and 333-217627) of Rexahn Pharmaceuticals, Inc., of our report dated March 7, 2019, relating to the financial statements of Rexahn Pharmaceuticals, Inc. which appear in this Annual Report on Form 10- K for the year ended December 31,
2018.
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP
Wyomissing, Pennsylvania
March 7, 2019